NCT05799898 Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
| NCT ID | NCT05799898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Mutualiste Montsouris |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2023-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-03-01 with a primary completion date of 2023-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors. Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors. Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.
Eligibility Criteria
Inclusion Criteria: * all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors Exclusion Criteria: * none
Contact & Investigator
Mariana Mirabel, MD, PhD
PRINCIPAL INVESTIGATOR
Institut Mutualiste Montsouris
Frequently Asked Questions
Who can join the NCT05799898 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05799898 currently recruiting?
Yes, NCT05799898 is actively recruiting participants. Contact the research team at isabelle.sauret@imm.fr for enrollment information.
Where is the NCT05799898 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT05799898 clinical trial?
NCT05799898 is sponsored by Institut Mutualiste Montsouris. The principal investigator is Mariana Mirabel, MD, PhD at Institut Mutualiste Montsouris. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.